Acrobiosystems for English
icon_bulk_orderBulk inquiry/Quick order
There is no goods in the shopping cart !
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0-9
Your Position: Home > Envelope protein

Envelope protein

Brief Information

Name:Recombinant envelope protein
Target Synonym:env,Submitted name: Recombinant envelope protein,Viral Envelope Proteins
Number of Launched Drugs:1
Number of Drugs in Clinical Trials:4
Lastest Research Phase:Approved

Product ListCompare or Buy

ACRO Quality

Part of Bioactivity data

Envelope protein MALS images

The purity of DENV2 (strain Thailand/16681/1984) Envelope Protein, His Tag (Cat. No. ENN-D5244) is more than 85% and the molecular weight of this protein is around 90-110 kDa verified by SEC-MALS.

 Envelope protein ELISA

Immobilized DENV2 (strain Thailand/16681/1984) Envelope Protein, His Tag (Cat. No. ENN-D5244) at 1 μg/mL (100 μL/well) can bind Human Anti-E(DENV) Antibody EDE2 A11,Human IgG1 | Human Kappa with a linear range of 1-39 ng/mL (QC tested).

Synonym Name

Envelope protein,Env polyprotein,Envelope glycoprotein,env


The SARS-CoV-2 is composed of a double-layered lipid envelope, including Spike glycoprotein (S), Envelope protein (E), Membrane glycoprotein (M), and Nucleocapsid protein (Nucleocapsid protein, N). Among them, The amino acid sequence of the SARS-CoV-2 envelope protein is 95% identical of the SARS envelope protein.

Clinical and Translational Updates

Public Drug Information

Name Research Code Research Phase Company First Brand Name First Approved Country First Indication First Approved Company First Approved Date Indications Clinical Trials
Tecovirimat SIGA-246; ST-246 Approved Siga Technologies Inc Tpoxx United States Smallpox Siga Technologies Inc 2018-07-13 Smallpox; Cowpox; Vaccinia; Poxviridae Infections; Monkeypox Details

Clinical Drug Information

Name Research Code Research Phase Company Indications Clinical Trials
Temelimab GNN-001; GENHP-01; GNbAC-1 Phase 2 Clinical Geneuro Sa Multiple Sclerosis, Relapsing-Remitting; Diabetes Mellitus, Type 1; Coronavirus Disease 2019 (COVID-19); Multiple Sclerosis Details
PGDM-1400 PGDM-1400; PGDM1400LS Phase 2 Clinical International Aids Vaccine Initiative HIV Infections; Acquired Immunodeficiency Syndrome; Retroviridae Infections; Sexually Transmitted Diseases, Viral; HIV Seropositivity Details
VIS-513 VIS-513; Ab-513 Phase 1 Clinical Otsuka Pharmaceutical Co Ltd, Serum Institute Of India Ltd, Visterra Inc Dengue Details
Targeting HIV-1 Env gp140 antibodies Phase 2 Clinical National Institute Of Allergy And Infectious Diseases (Niaid) HIV Infections Details

This web search service is supported by Google Inc.

Call us
Call us
North America:
+1 800-810-0816 (Toll Free)
Asia & Pacific:
+86 400-682-2521
+1 888-377-6111
1 Innovation Way, Newark, DE 19711, USA

Leave a message